Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
More news for Wednesday, Feb. 22
By
Kimberly Bonvissuto
Feb 22, 2023
Congressman tells AG Garland that Esformes case is ‘political’ … FHCA unveils 2023 legislative priorities … Medicare advisers suggest tweak to coverage process for Alzheimer’s drugs … Schumer...
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Lawmakers seek passage of two bills that would help prevent, treat Alzheimer’s
By
Kimberly Bonvissuto
Nov 22, 2022
Two lawmakers are asking for support of two bipartisan bills to ensure the nation has the ability to continue both immediate and long-term planning in its battle against Alzheimer’s disease and related...
Raise grant rates for assisted living, wages and benefits for caregivers, board recommends
By
Kimberly Bonvissuto
Oct 05, 2022
A state government advisory board is recommending that the Virginia General Assembly increase grant awards to cover assisted living costs, mandate sick leave and a living wage for direct care workers,...
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.